TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27253658

Group type: EXPERIMENTAL
Intervention: Suvorexant (40, 80, and 150 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Suvorexant (all doses)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Suvorexant
Number of subjects: 36

Group type: COMPARATOR
Intervention: Zolpidem (15 and 30 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 24385309

Group type: EXPERIMENTAL
Intervention: Quetiapine XR 300 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Quetiapine XR 600 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Quetiapine XR 800 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Quetiapine XR (all doses)
Number of subjects: 40
Study: 23623623

Group type: EXPERIMENTAL
Intervention: In-Home Cognitive Behavioral Therapy (IH-CBT)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Standard Home Visiting (SHV)
Number of subjects: 93
Study: 21052041

Group type: EXPERIMENTAL
Intervention: venlafaxine ER (75 to 225 mg/d)
Number of subjects: 520

Group type: COMPARATOR
Intervention: venlafaxine ER + Dialogues program
Number of subjects: 520
Study: 18376124

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 678

Group type: COMPARATOR
Intervention: Verapamil
Number of subjects: 678

Group type: EXPERIMENTAL
Intervention: DI (Differential Index)
Number of subjects: 678

Group type: EXPERIMENTAL
Intervention: SDNN (Standard Deviation of Normal-to-Normal intervals)
Number of subjects: 678

Group type: EXPERIMENTAL
Intervention: PNN50 (Percent of differences between adjacent normal RR intervals >50 ms)
Number of subjects: 678

Group type: EXPERIMENTAL
Intervention: RMSSD (Root Mean Square of Successive Differences)
Number of subjects: 678

Group type: EXPERIMENTAL
Intervention: Overall HRV measurements
Number of subjects: 678
Study: 16632013

Group type: EXPERIMENTAL
Intervention: Valsartan, 80 mg/d (titrated up to 160 mg/d for blood pressure control)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study: 12954916

Group type: EXPERIMENTAL
Intervention: Cholesterol-reducing drugs
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 10963823

Group type: EXPERIMENTAL
Intervention: Insulin aspart (0.025 U/kg BW)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin aspart (0.05 U/kg BW)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Human insulin (0.025 U/kg BW)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Human insulin (0.05 U/kg BW)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin aspart (any dose)
Number of subjects: 0
Study: 8626983

Group type: EXPERIMENTAL
Intervention: House dust mite inhalation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo inhalation
Number of subjects: 20
Study: 8139394

Group type: EXPERIMENTAL
Intervention: Fish oil (30 g/d)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Olive oil
Number of subjects: 20
Study: 3413202

Group type: EXPERIMENTAL
Intervention: Zolpidem 20 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 29368598

Group type: EXPERIMENTAL
Intervention: Supervised progressive resistance exercise program (RT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aerobic exercise program (AT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment/control (CN)
Number of subjects: 0
Study: 28118486

Group type: EXPERIMENTAL
Intervention: Behavioral sleep intervention
Number of subjects: 42

Group type: COMPARATOR
Intervention: Healthy Behaviors (Control)
Number of subjects: 42
Study: 27310241

Group type: EXPERIMENTAL
Intervention: Telephone coaching provided by trained lay coaches
Number of subjects: 223

Group type: COMPARATOR
Intervention: Baseline psychological treatment
Number of subjects: 223

Group type: COMPARATOR
Intervention: Baseline antidepressant medications
Number of subjects: 223
Study: 23733443

Group type: EXPERIMENTAL
Intervention: HiDHA (tuna oil) supplementation (8 × 1 g capsules per day for 16 weeks)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Olive oil (placebo) supplementation (8 × 1 g capsules per day for 16 weeks)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Correlation analysis in the fish oil group
Number of subjects: 95
Study: 21414950

Group type: EXPERIMENTAL
Intervention: Symptom-triggered self-medication with chlordiazepoxide
Number of subjects: 165

Group type: COMPARATOR
Intervention: Fixed-schedule regimen with chlordiazepoxide
Number of subjects: 165
Study: 19108693

Group type: EXPERIMENTAL
Intervention: Ad5 vaccine
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: MRKAd5 vaccine
Number of subjects: 252

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 252
Study: 17884364

Group type: EXPERIMENTAL
Intervention: DANAMI score
Number of subjects: 1115

Group type: COMPARATOR
Intervention: Veterans Affairs Medical Center score
Number of subjects: 1115

Group type: COMPARATOR
Intervention: Duke treadmill score
Number of subjects: 1115

Group type: COMPARATOR
Intervention: GISSI-2 score
Number of subjects: 1115
Study: 15364161

Group type: EXPERIMENTAL
Intervention: Morning dose of insulin glargine
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Evening dose of insulin glargine
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Split dose of insulin glargine
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: All groups combined
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: All groups (morning, evening, split)
Number of subjects: 292
Study: 11998881

Group type: EXPERIMENTAL
Intervention: Radiotherapy (20 Gy in 10 fractions)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (15 patients, 4 well-defined, 11 occult)
Number of subjects: 27
Study: 9894621

Group type: EXPERIMENTAL
Intervention: Captopril (37.5 mg/day)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 8672317

Group type: EXPERIMENTAL
Intervention: Digital pressure applied on the neurovascular sheath during injection of 2% mepivacaine with adrenaline (20 ml) mixed with contrast agent (20 ml).
Number of subjects: 98

Group type: COMPARATOR
Intervention: Digital pressure applied 6-8 cm below the neurovascular sheath during injection of 2% mepivacaine with adrenaline (20 ml) mixed with contrast agent (20 ml).
Number of subjects: 98
Study: 2088996

Group type: EXPERIMENTAL
Intervention: 30‐mg controlled‐release morphine tablet (MS Contin Tablet) after a high fat meal
Number of subjects: 24

Group type: COMPARATOR
Intervention: 30‐mg controlled‐release morphine tablet (MS Contin Tablet) after fasting
Number of subjects: 24
Study: 391321

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pethidine
Number of subjects: 0
Study: 31221211

Group type: EXPERIMENTAL
Intervention: Theory-based implementation approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-theory based implementation approach
Number of subjects: 0
Study: 28738490

Group type: EXPERIMENTAL
Intervention: Ultrafiltration therapy for 8 hours
Number of subjects: 132

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 132
Study: 25099637

Group type: EXPERIMENTAL
Intervention: Minimally invasive retroperitoneal approach (RPA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Transperitoneal approach (TPA)
Number of subjects: 60
Study: 23665375

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for 12 weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: Healthy Control (HC) participants
Number of subjects: 14
Study: 21233258

Group type: EXPERIMENTAL
Intervention: Sympathectomy at the third thoracic ganglion (G3)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sympathectomy at the fourth thoracic ganglion (G4)
Number of subjects: 40
Study: 18423715

Group type: EXPERIMENTAL
Intervention: Interactive spaced education on prostate cancer/prostate specific antigen
Number of subjects: 237

Group type: COMPARATOR
Intervention: Web based teaching on benign prostatic hyperplasia/erectile dysfunction
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Interactive spaced education on benign prostatic hyperplasia/erectile dysfunction
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Interactive spaced education
Number of subjects: 237

Group type: COMPARATOR
Intervention: Web based teaching
Number of subjects: 237
Study: 16551138

Group type: EXPERIMENTAL
Intervention: Family Check-Up intervention
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study: 14618096

Group type: EXPERIMENTAL
Intervention: Aprotinin 0.5 x 10(5) KIU/Kg (Group B)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Aprotinin 1.0 x 10(5) KIU/Kg (Group C)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (Group A)
Number of subjects: 32
Study: 10891980

Group type: EXPERIMENTAL
Intervention: Microelectrode‐guided bilateral STN high‐frequency stimulation
Number of subjects: 15
Study: 1932608

Group type: EXPERIMENTAL
Intervention: Combination tablet of enalapril (10 mg) and hydrochlorothiazide (25 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Enalapril tablet (10 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hydrochlorothiazide tablet (25 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Simultaneous administration of separate tablets of enalapril (10 mg) and hydrochlorothiazide (25 mg)
Number of subjects: 12
Study: 7015537

Group type: EXPERIMENTAL
Intervention: Oxprenolol HCl 160 mg slow-release plus cyclopenthiazide 0.25 mg and potassium chloride 600 mg
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Similar regimen (not specified)
Number of subjects: 89
Study: 31865273

Group type: EXPERIMENTAL
Intervention: Fingolimod
Number of subjects: 530
Study: 30025819

Group type: EXPERIMENTAL
Intervention: HER2-peptide vaccines
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control patients (HLA-A2 negative)
Number of subjects: 0
Study: 27514617

Group type: EXPERIMENTAL
Intervention: 20 mg prasugrel
Number of subjects: 40

Group type: COMPARATOR
Intervention: 300 mg clopidogrel
Number of subjects: 40
Study: 24522636

Group type: EXPERIMENTAL
Intervention: COPD Assessment Test (CAT)
Number of subjects: 824

Group type: EXPERIMENTAL
Intervention: modified Medical Research Council (mMRC) scale
Number of subjects: 824

Group type: EXPERIMENTAL
Intervention: Changes in mMRC scale scores
Number of subjects: 824

Group type: COMPARATOR
Intervention: COPD Assessment Test (CAT) in smokers without COPD
Number of subjects: 824
Study: 21255943

Group type: EXPERIMENTAL
Intervention: Boost arm (45 Gy in 25 fractions to the whole breast followed by a 16 Gy in 8 fraction electron boost)
Number of subjects: 688

Group type: COMPARATOR
Intervention: No-boost arm (50 Gy in 25 fractions)
Number of subjects: 688
Study: 18793808

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 166

Group type: COMPARATOR
Intervention: Control
Number of subjects: 166
Study: 18034674

Group type: EXPERIMENTAL
Intervention: Restorative dental materials in clinical trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laboratory test values
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risk assessment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Evidence-based dentistry
Number of subjects: 0
Study: 16144987

Group type: EXPERIMENTAL
Intervention: Valsartan (160 mg/d) administered at bedtime
Number of subjects: 200

Group type: COMPARATOR
Intervention: Valsartan (160 mg/d) administered on awakening
Number of subjects: 200
Study: 12117040

Group type: EXPERIMENTAL
Intervention: Formoterol (4.5, 18, and 54 microg via Turbuhaler)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Salbutamol (200 and 1800 microg via pMDI)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 10427133

Group type: EXPERIMENTAL
Intervention: ex vivo expanded hematopoietic cells and progenitors
Number of subjects: 6
Study: 7489584

Group type: EXPERIMENTAL
Intervention: Aktiferrin capsules
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tardyferon dragées
Number of subjects: 40
Study: 2140965

Group type: EXPERIMENTAL
Intervention: Intermittent lower-body positive pressure (LBPP) for 10 min periods
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Continuous lower-body positive pressure (LBPP) for 90 min
Number of subjects: 8
Study: 6896406

Group type: EXPERIMENTAL
Intervention: Allopurinol (xanthine oxidase inhibitor)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 29145788

Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT) delivered via videoconferencing
Number of subjects: 251

Group type: COMPARATOR
Intervention: Cognitive Processing Therapy (CPT) delivered in-person
Number of subjects: 251
Study: 29555631

Group type: EXPERIMENTAL
Intervention: Rezafungin (CD101) administered intravenously
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rezafungin (CD101)
Number of subjects: 0
Study: 27401052

Group type: EXPERIMENTAL
Intervention: Benefit-finding intervention (gain-focused reappraisal strategies)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Simplified psychoeducation (lectures only)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Standard psychoeducation
Number of subjects: 129
Study: 24738800

Group type: EXPERIMENTAL
Intervention: Marsh model in effect-site control mode with a ke0 of 0.6 min(‐1)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Marsh model in effect-site control mode with a ke0 of 1.2 min(‐1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Marsh model in blood concentration control
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Schnider model in effect-site control
Number of subjects: 80
Study: 24159790

Group type: EXPERIMENTAL
Intervention: Cycloferon (7.5 g) combined with antibacterial therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study: 20735821

Group type: EXPERIMENTAL
Intervention: Triple anti-platelet therapy (cilostazol, aspirin, clopidogrel)
Number of subjects: 960

Group type: COMPARATOR
Intervention: Dual anti-platelet therapy (aspirin and clopidogrel)
Number of subjects: 960

Group type: EXPERIMENTAL
Intervention: Triple anti-platelet therapy
Number of subjects: 960

Group type: COMPARATOR
Intervention: Dual anti-platelet therapy
Number of subjects: 960
Study: 18426639

Group type: EXPERIMENTAL
Intervention: 1 mg folic acid daily
Number of subjects: 140

Group type: COMPARATOR
Intervention: 5 mg folic acid weekly
Number of subjects: 140
Study: 15832337

Group type: EXPERIMENTAL
Intervention: Exposure metrics from 16 exposed EDF employees
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control subjects (15 individuals)
Number of subjects: 31
Study: 12813158

Group type: EXPERIMENTAL
Intervention: Landing on an inverting surface (25 degrees of rotation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Landing on a non-inverting surface
Number of subjects: 0
Study: 10481354

Group type: EXPERIMENTAL
Intervention: Tele-medicine system for asthma management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 0
Study: 8630564

Group type: EXPERIMENTAL
Intervention: Patient-triggered ventilation (PTV) with peak inspiratory pressure of 10 cm H2O (PTV10)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Patient-triggered ventilation (PTV) with peak inspiratory pressure of 15 cm H2O (PTV15)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Intermittent mandatory ventilation (IMV)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Spontaneous ventilation with continuous positive airway pressure
Number of subjects: 6
Study: 2026848

Group type: EXPERIMENTAL
Intervention: High-dose intravenous immunoglobulin (IVIG)
Number of subjects: 8
Study: 7290755

Group type: EXPERIMENTAL
Intervention: GSR response to target stimuli
Number of subjects: 20

Group type: COMPARATOR
Intervention: GSR response to nontarget stimuli
Number of subjects: 20
Study: 31914291

Group type: EXPERIMENTAL
Intervention: Manual reduction combined with vestibular rehabilitation exercises
Number of subjects: 186

Group type: COMPARATOR
Intervention: Manual reduction
Number of subjects: 186
Study: 27717222

Group type: EXPERIMENTAL
Intervention: Exenatide once-weekly (subcutaneous injections)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 25648901

Group type: EXPERIMENTAL
Intervention: Diaphragm pacing (DP) using implanted electrodes
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Diaphragm pacing (DP)
Number of subjects: 53
Study: 25057189

Group type: EXPERIMENTAL
Intervention: Visual short-term memory (vSTM) task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enumeration task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Posterior parietal cortex (PPC) activation during both tasks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multivariate pattern analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Computational model of PPC using saliency map architecture
Number of subjects: 0
Study: 22028071

Group type: EXPERIMENTAL
Intervention: 20 µg of HyD per day
Number of subjects: 20

Group type: COMPARATOR
Intervention: 20 µg (800 IU) of vitamin D(3) per day
Number of subjects: 20
Study: 19687105

Group type: EXPERIMENTAL
Intervention: Small-group, interactive education about asthma
Number of subjects: 398

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 398
Study: 17296405

Group type: EXPERIMENTAL
Intervention: Transurethral ethanol ablation of the prostate (15%, 25%, or 40% of prostate volume)
Number of subjects: 79
Study: 15365075

Group type: EXPERIMENTAL
Intervention: Ambulatory management
Number of subjects: 149

Group type: COMPARATOR
Intervention: Hospital-based management
Number of subjects: 149
Study: 11715806

Group type: EXPERIMENTAL
Intervention: CRASH study intervention
Number of subjects: 20000
Study: 9711797

Group type: EXPERIMENTAL
Intervention: 10 micrograms of recombinant hepatitis B vaccine (GenHevac B) intramuscularly (i.m.)
Number of subjects: 400

Group type: COMPARATOR
Intervention: 2 micrograms of recombinant hepatitis B vaccine (GenHevac B) intradermally (ID)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: 10 micrograms i.m. versus 2 micrograms ID
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: 2 micrograms ID
Number of subjects: 400
Study: 7974084

Group type: EXPERIMENTAL
Intervention: Cobalt-60 therapy followed by hormonotherapy after progression
Number of subjects: 48

Group type: COMPARATOR
Intervention: Primary hormonotherapy with LH-RH analogue +/- Flutamide
Number of subjects: 48
Study: 2566391

Group type: EXPERIMENTAL
Intervention: Esmolol (500 micrograms.kg‐1.min‐1 X 6 minutes, followed by 300 micrograms.kg‐1.min‐1 X 9 minutes)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fentanyl (0.8 microgram.kg‐1.min‐1 X 10 minutes)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 1094528

Group type: EXPERIMENTAL
Intervention: Listerine mouthrinse
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 10
Study: 31912784

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for 12 weeks
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Graded Exercise Therapy (GET) for 12 weeks
Number of subjects: 134

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 134
Study: 31361018

Group type: EXPERIMENTAL
Intervention: Laser enrichment
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1200
Study: 28777749

Group type: EXPERIMENTAL
Intervention: Multidomain lifestyle intervention (diet, exercise, cognitive training, and vascular risk management)
Number of subjects: 1260

Group type: COMPARATOR
Intervention: General health advice (Control)
Number of subjects: 1260
Study: 24973891

Group type: EXPERIMENTAL
Intervention: Wraparound care coordination
Number of subjects: 93

Group type: COMPARATOR
Intervention: Intensive case management (ICM)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Wraparound
Number of subjects: 93
Study: 23957590

Group type: EXPERIMENTAL
Intervention: Probiotic mixture (Lactobacillus paracasei ssp paracasei F19, Lactobacillus acidophilus La5, Bifidobacterium Bb12) 1.3 × 10(10) CFU per capsule, two capsules twice daily for 6 months
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo, two capsules twice daily for 6 months
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Probiotic and Placebo (both groups)
Number of subjects: 131
Study: 21834970

Group type: EXPERIMENTAL
Intervention: Enhanced pharmacist care (patient identification, assessment, education, close follow‐up, and prescribing/titration of antihypertensive medications)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 18613226

Group type: EXPERIMENTAL
Intervention: Generalized estimating equations (GEE) with identity link
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cluster-level method using proportions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cluster-level method using log proportions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cluster-level method using log odds
Number of subjects: 0
Study: 16181005

Group type: EXPERIMENTAL
Intervention: Symbicort Turbuhaler
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Seretide Diskus
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both products
Number of subjects: 0
Study: 14678587

Group type: EXPERIMENTAL
Intervention: Comprehensive adherence package (education programme, individualized planning, adherence aids)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control (no adherence package)
Number of subjects: 43
Study: 10655008

Group type: EXPERIMENTAL
Intervention: Rosenberg Self-Esteem Scale
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Vocational rehabilitation
Number of subjects: 143
Study: 8669654

Group type: EXPERIMENTAL
Intervention: PCEA fentanyl
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: PCEA pethidine
Number of subjects: 45
Study: 1734400

Group type: COMPARATOR
Intervention: Racemic epinephrine
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: L-epinephrine
Number of subjects: 31
Study: 6704838

Group type: EXPERIMENTAL
Intervention: 10 well-baby visits
Number of subjects: 570

Group type: COMPARATOR
Intervention: 5 well-baby visits
Number of subjects: 570
Study: 30852650

Group type: EXPERIMENTAL
Intervention: MiraLAX
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Breeza
Number of subjects: 75

Group type: COMPARATOR
Intervention: VoLumen
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: All preparations
Number of subjects: 75
Study: 29167974

Group type: EXPERIMENTAL
Intervention: Transvaginal mesh placement
Number of subjects: 194

Group type: COMPARATOR
Intervention: Native tissue repair
Number of subjects: 194